EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy: Advancement and Challenges

Stephanie Efthymiou iD, Richard J L F Lemmers, Venugopalan Y Vishnu iD, Natalia Dominik, Benedetta Perrone, Stefano Facchini, Elisa Vegezzi, Sabrina Ravaglia iD, Lindsay Wilson, Patrick J van der Vliet, Rinkle Mishra, Alisha Reyaz und 9 weitere

Biomolecules · 2023

DOI: 10.3390/biom13111567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Stephanie Efthymiou und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK. Hauptthemen laut MEDLINE: Muscular Dystrophy, Facioscapulohumeral. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, National Brain Appeal’s Innovation Fund, Rosetrees Trust grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Facioscapulohumeral muscular dystrophy (FSHD) is the second most common muscular dystrophy in adults, and it is associated with local D4Z4 chromatin relaxation, mostly via the contraction of the D4Z4 macrosatellite repeat array on chromosome 4q35. In this study, we aimed to investigate the use of Optical Genome Mapping (OGM) as a diagnostic tool for testing FSHD cases from the UK and India and to compare OGM performance with that of traditional techniques such as linear gel (LGE) and Pulsed-field gel electrophoresis (PFGE) Southern blotting (SB). A total of 6 confirmed and 19 suspected FSHD samples were processed with LGE and PFGE, respectively. The same samples were run using a Saphyr Genome-Imaging Instrument (1-color), and the data were analysed using custom EnFocus FSHD analysis. OGM was able to confirm the diagnosis of FSHD1 in all FSHD1 cases positive for SB (n = 17), and D4Z4 sizing highly correlated with PFGE-SB (p < 0.001). OGM correctly identified cases with mosaicism for the repeat array contraction (n = 2) and with a duplication of the D4Z4 repeat array. OGM is a promising new technology able to unravel structural variants in the genome and seems to be a valid tool for diagnosing FSHD1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, FacioscapulohumeralAdultHumansElectrophoresis, Gel, Pulsed-FieldChromosome MappingIndia

Stichwörter der Autor:innen

Bionano GenomicsD4Z4 contractionFSHDoptical genome mapping

Autor:innen und Institutionen

  • Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
  • Department of Human Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Department of Neurology, All India Institute of Medical Sciences, New Delhi 110029, India.
  • IRCCS Mondino Foundation, 27100 Pavia, Italy.
  • Neurogenetics Laboratory, National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK.

ORCID-Profile: Stephanie Efthymiou, Venugopalan Y Vishnu, Sabrina Ravaglia, Silvère M van der Maarel, Enrico Bugiardini

Förderung

  • Medical Research Council
  • National Brain Appeal’s Innovation Fund
  • Rosetrees Trust grant
  • AIIMS:UCL intramural grant
  • Friends of F.S.H. Research
  • International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD)

Zitieren

APA

Efthymiou, S., Lemmers, R. J. L. F., Vishnu, V. Y., Dominik, N., Perrone, B., Facchini, S., Vegezzi, E., Ravaglia, S., Wilson, L., van der Vliet, P. J., Mishra, R., Reyaz, A., Ahmad, T., Bhatia, R., Polke, J. M., Srivastava, M. P., Cortese, A., Houlden, H., van der Maarel, S. M., …, & Bugiardini, E. (2023). Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy: Advancement and Challenges. Biomolecules. https://doi.org/10.3390/biom13111567

Vancouver

Efthymiou S, Lemmers RJLF, Vishnu VY, Dominik N, Perrone B, Facchini S, et al. Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy: Advancement and Challenges. Biomolecules. 2023. doi:10.3390/biom13111567

BibTeX
@article{Efthymiou2023,
  author = {Efthymiou, Stephanie and Lemmers, Richard J L F and Vishnu, Venugopalan Y and Dominik, Natalia and Perrone, Benedetta and Facchini, Stefano and Vegezzi, Elisa and Ravaglia, Sabrina and Wilson, Lindsay and van der Vliet, Patrick J and Mishra, Rinkle and Reyaz, Alisha and Ahmad, Tanveer and Bhatia, Rohit and Polke, James M and Srivastava, Mv Padma and Cortese, Andrea and Houlden, Henry and van der Maarel, Silvère M and Hanna, Michael G and Bugiardini, Enrico},
  title = {Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy: Advancement and Challenges},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13111567}
}
Kostenlos starten →